Page 1 of 53
D116 - ADVANCED PHARMACOLOGY- ( 100 )
PRACTICE QUESTIONS WITH RADICLE
RATIONALES
Nursing
Exam coverage :
• Section 1 (Q1-25): Pharmacokinetics,
pharmacodynamics, receptor theory, drug interactions,
toxicity, and therapeutic index.
• Section 2 (Q26-50): Drug metabolism (CYP450), genetic
polymorphisms, antidotes, drug classes, and evidence-
based prescribing.
• Section 3 (Q51-75): Hazard hierarchy (engineering
controls), TPM, behavioral safety (ABC model),
ergonomics, ventilation, and process safety.
• Section 4 (Q76-100): Six Sigma, lockout/tagout, human
factors, PPE, root cause analysis, leading indicators, and
continuous improvement (Kaizen).
1. In advanced pharmacology, the clinical efficacy of a drug
is primarily determined by its affinity for the target receptor
and its intrinsic activity. Which property of a drug defines it
as a full agonist at a specific receptor site?
A) High affinity with low intrinsic activity.
B) Low affinity with high intrinsic activity.
C) Maximum intrinsic activity (efficacy = 1.0) regardless of
affinity. ✓ (CORRECT)
, Page 2 of 53
D) Competitive binding with the endogenous ligand.
E) Irreversible covalent bonding to the receptor.
RATIONALE: A FULL AGONIST PRODUCES A MAXIMAL
BIOLOGICAL RESPONSE (EFFICACY = 1.0) WHEN OCCUPYING
THE RECEPTOR. AFFINITY DETERMINES POTENCY, BUT
INTRINSIC ACTIVITY DETERMINES EFFICACY.
2. When prescribing a medication with a narrow therapeutic
index (NTI) such as warfarin or digoxin, which
pharmacokinetic parameter is most critical for the advanced
practice nurse to monitor to prevent toxicity?
A) Volume of distribution (Vd).
B) Elimination half-life (t½).
C) Drug plasma concentration relative to the minimum effective
concentration (MEC).
D) Area under the curve (AUC).
E) Steady-state concentration (Css) achieved at a given dose.
✓ (CORRECT)
RATIONALE: FOR NTI DRUGS, THE STEADY-STATE
CONCENTRATION MUST BE MAINTAINED WITHIN A NARROW
WINDOW BETWEEN THE MEC AND THE MINIMUM TOXIC
CONCENTRATION (MTC). MONITORING Css ALLOWS PRECISE
DOSE ADJUSTMENTS TO AVOID SUPRATHERAPEUTIC LEVELS.
3. In the context of pharmacodynamics, what is the most
accurate description of a drug that acts as a competitive
antagonist at the beta-1 adrenergic receptor?
A) It binds to the receptor and activates a downstream signaling
cascade.
, Page 3 of 53
B) It binds to an allosteric site, changing the receptor
conformation.
C) It reversibly binds to the active site, preventing the
endogenous agonist from binding. ✓ (CORRECT)
D) It irreversibly destroys the receptor protein.
E) It increases the synthesis of the endogenous ligand.
RATIONALE: COMPETITIVE ANTAGONISTS REVERSIBLY
OCCUPY THE SAME BINDING SITE AS THE AGONIST. THEIR
EFFECT CAN BE OVERCOME BY INCREASING THE AGONIST
CONCENTRATION (SHIFT IN THE DOSE-RESPONSE CURVE TO
THE RIGHT).
4. Considering the latest FDA guidelines on opioid
prescribing, which patient-specific factor is the strongest
predictor for the development of opioid-induced respiratory
depression?
A) History of tobacco use.
B) Concurrent use of benzodiazepines or other CNS
depressants. ✓ (CORRECT)
C) Presence of hypertension.
D) Body mass index greater than 30.
E) Age younger than 18 years.
RATIONALE: CONCURRENT USE OF BENZODIAZEPINES,
OTHER OPIOIDS, OR ALCOHOL POTENTIATES RESPIRATORY
DEPRESSION THROUGH ADDITIVE CNS DEPRESSANT EFFECTS,
SIGNIFICANTLY INCREASING THE RISK OF FATAL OVERDOSE.
5. In advanced pharmacology, the concept of "drug
tolerance" is best explained by which of the following
, Page 4 of 53
adaptive physiological mechanisms?
A) Decreased drug absorption from the gastrointestinal tract.
B) Increased renal excretion of the active drug metabolite.
C) Down-regulation or desensitization of target receptors
following chronic exposure. ✓ (CORRECT)
D) Increased plasma protein binding reducing free drug
concentration.
E) Induction of CYP450 enzymes leading to faster metabolism.
RATIONALE: TOLERANCE PRIMARILY OCCURS DUE TO
RECEPTOR DOWN-REGULATION (REDUCED NUMBER) OR
DESENSITIZATION (REDUCED SIGNALING EFFICIENCY) AFTER
PROLONGED AGONIST EXPOSURE, REQUIRING HIGHER
DOSES TO ACHIEVE THE SAME EFFECT.
6. When managing a patient with chronic heart failure, the
advanced practice nurse prescribes an angiotensin-
converting enzyme (ACE) inhibitor. What is the primary
pharmacodynamic mechanism by which ACE inhibitors
reduce afterload?
A) Direct vasodilation of venous capacitance vessels.
B) Blockade of angiotensin II type 1 (AT1) receptors.
C) Inhibition of angiotensin II production, reducing systemic
vascular resistance. ✓ (CORRECT)
D) Increased excretion of sodium and water through diuresis.
E) Stimulation of beta-2 receptors causing bronchodilation.
RATIONALE: ACE INHIBITORS PREVENT THE CONVERSION OF
ANGIOTENSIN I TO ANGIOTENSIN II (A POTENT
VASOCONSTRICTOR). REDUCED ANGIOTENSIN II LEADS TO
DECREASED SYSTEMIC VASCULAR RESISTANCE (AFTERLOAD),
WHICH IMPROVES CARDIAC OUTPUT.
D116 - ADVANCED PHARMACOLOGY- ( 100 )
PRACTICE QUESTIONS WITH RADICLE
RATIONALES
Nursing
Exam coverage :
• Section 1 (Q1-25): Pharmacokinetics,
pharmacodynamics, receptor theory, drug interactions,
toxicity, and therapeutic index.
• Section 2 (Q26-50): Drug metabolism (CYP450), genetic
polymorphisms, antidotes, drug classes, and evidence-
based prescribing.
• Section 3 (Q51-75): Hazard hierarchy (engineering
controls), TPM, behavioral safety (ABC model),
ergonomics, ventilation, and process safety.
• Section 4 (Q76-100): Six Sigma, lockout/tagout, human
factors, PPE, root cause analysis, leading indicators, and
continuous improvement (Kaizen).
1. In advanced pharmacology, the clinical efficacy of a drug
is primarily determined by its affinity for the target receptor
and its intrinsic activity. Which property of a drug defines it
as a full agonist at a specific receptor site?
A) High affinity with low intrinsic activity.
B) Low affinity with high intrinsic activity.
C) Maximum intrinsic activity (efficacy = 1.0) regardless of
affinity. ✓ (CORRECT)
, Page 2 of 53
D) Competitive binding with the endogenous ligand.
E) Irreversible covalent bonding to the receptor.
RATIONALE: A FULL AGONIST PRODUCES A MAXIMAL
BIOLOGICAL RESPONSE (EFFICACY = 1.0) WHEN OCCUPYING
THE RECEPTOR. AFFINITY DETERMINES POTENCY, BUT
INTRINSIC ACTIVITY DETERMINES EFFICACY.
2. When prescribing a medication with a narrow therapeutic
index (NTI) such as warfarin or digoxin, which
pharmacokinetic parameter is most critical for the advanced
practice nurse to monitor to prevent toxicity?
A) Volume of distribution (Vd).
B) Elimination half-life (t½).
C) Drug plasma concentration relative to the minimum effective
concentration (MEC).
D) Area under the curve (AUC).
E) Steady-state concentration (Css) achieved at a given dose.
✓ (CORRECT)
RATIONALE: FOR NTI DRUGS, THE STEADY-STATE
CONCENTRATION MUST BE MAINTAINED WITHIN A NARROW
WINDOW BETWEEN THE MEC AND THE MINIMUM TOXIC
CONCENTRATION (MTC). MONITORING Css ALLOWS PRECISE
DOSE ADJUSTMENTS TO AVOID SUPRATHERAPEUTIC LEVELS.
3. In the context of pharmacodynamics, what is the most
accurate description of a drug that acts as a competitive
antagonist at the beta-1 adrenergic receptor?
A) It binds to the receptor and activates a downstream signaling
cascade.
, Page 3 of 53
B) It binds to an allosteric site, changing the receptor
conformation.
C) It reversibly binds to the active site, preventing the
endogenous agonist from binding. ✓ (CORRECT)
D) It irreversibly destroys the receptor protein.
E) It increases the synthesis of the endogenous ligand.
RATIONALE: COMPETITIVE ANTAGONISTS REVERSIBLY
OCCUPY THE SAME BINDING SITE AS THE AGONIST. THEIR
EFFECT CAN BE OVERCOME BY INCREASING THE AGONIST
CONCENTRATION (SHIFT IN THE DOSE-RESPONSE CURVE TO
THE RIGHT).
4. Considering the latest FDA guidelines on opioid
prescribing, which patient-specific factor is the strongest
predictor for the development of opioid-induced respiratory
depression?
A) History of tobacco use.
B) Concurrent use of benzodiazepines or other CNS
depressants. ✓ (CORRECT)
C) Presence of hypertension.
D) Body mass index greater than 30.
E) Age younger than 18 years.
RATIONALE: CONCURRENT USE OF BENZODIAZEPINES,
OTHER OPIOIDS, OR ALCOHOL POTENTIATES RESPIRATORY
DEPRESSION THROUGH ADDITIVE CNS DEPRESSANT EFFECTS,
SIGNIFICANTLY INCREASING THE RISK OF FATAL OVERDOSE.
5. In advanced pharmacology, the concept of "drug
tolerance" is best explained by which of the following
, Page 4 of 53
adaptive physiological mechanisms?
A) Decreased drug absorption from the gastrointestinal tract.
B) Increased renal excretion of the active drug metabolite.
C) Down-regulation or desensitization of target receptors
following chronic exposure. ✓ (CORRECT)
D) Increased plasma protein binding reducing free drug
concentration.
E) Induction of CYP450 enzymes leading to faster metabolism.
RATIONALE: TOLERANCE PRIMARILY OCCURS DUE TO
RECEPTOR DOWN-REGULATION (REDUCED NUMBER) OR
DESENSITIZATION (REDUCED SIGNALING EFFICIENCY) AFTER
PROLONGED AGONIST EXPOSURE, REQUIRING HIGHER
DOSES TO ACHIEVE THE SAME EFFECT.
6. When managing a patient with chronic heart failure, the
advanced practice nurse prescribes an angiotensin-
converting enzyme (ACE) inhibitor. What is the primary
pharmacodynamic mechanism by which ACE inhibitors
reduce afterload?
A) Direct vasodilation of venous capacitance vessels.
B) Blockade of angiotensin II type 1 (AT1) receptors.
C) Inhibition of angiotensin II production, reducing systemic
vascular resistance. ✓ (CORRECT)
D) Increased excretion of sodium and water through diuresis.
E) Stimulation of beta-2 receptors causing bronchodilation.
RATIONALE: ACE INHIBITORS PREVENT THE CONVERSION OF
ANGIOTENSIN I TO ANGIOTENSIN II (A POTENT
VASOCONSTRICTOR). REDUCED ANGIOTENSIN II LEADS TO
DECREASED SYSTEMIC VASCULAR RESISTANCE (AFTERLOAD),
WHICH IMPROVES CARDIAC OUTPUT.
